Glenn Frank Short - 03 Mar 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Chief Scientific Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
03 Mar 2025
Net transactions value
$0
Form type
4
Filing time
06 Mar 2025, 09:10:48 UTC
Previous filing
10 Jan 2025
Next filing
19 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +757,915 $0.000000 757,915 03 Mar 2025 Common Shares 757,915 $1.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest as to 25% on January 1, 2026, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.